Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion

Journal of Endocrinology

Volumn 199, Issue 2, 2008, Pages 235-242

  Costa da Veiga, Marco Aurélio Liberato ^a   Bloise, Flávia Fonseca ^a   Costa e Sousa, Ricardo Henrique ^a   Souza, Luana Lopes ^a   dos Santos Almeida, Norma Aparecida ^a   Oliveira, Karen Jesus ^a,b   Pazos Moura, Carmen Cabanelas ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; LIOTHYRONINE; THYROXINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; PIPERIDINES; PITUITARY GLAND; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 56849109623     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0380     Document Type: Article

References (37)

1. Antunes-Rodrigues J & McCann SM 1970 Water, sodium chloride, and food intake induced by injections of cholinergic and adrenergic drugs into third ventricle of the rat brain. Proceedings of the Society for Experimental Biology and Medicine 133 1464-1470.
2. Chambers AP, Sharkey KA & Koopmans HS 2004 Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat. Physiology and Behavior 82 863-869.
3. Chard T 1987 An introduction to radioimmunoassay and related techniques. In Laboratory Techniques in Biochemistry and Molecular Biology, pp 1-74. Eds RH Burdon & H van Kiniooenberg. Amsterdam: Elsevier Science.
4. Devane WA, Dysarz FA, Johnson MR, Melvin LS & Howlett AC 1988 Determination and characterization of a cannabinoid receptor in rat-brain. Molecular Pharmacology 34 605-613.
5. Fernandez-Ruiz J, Munoz RM, Romero J, Villanua MA, Makriyannis A & Ramos JA 1997 Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochemical Pharmacology 53 1919-1927.
6. Fernandez-Solari J, Scorticati C, Mohn C, De Laurentiis A, Billi S, Franchi A, McCann SM & Rettori V 2004 Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. PNAS 101 3264-3268.
7. Foster-Schubert KE & Cummings DE 2006 Emerging therapeutic strategies for obesity. Endocrine Reviews 27 779-793.
8. Gatley SJ, Gifford AN, Volkow ND, Lan RX & Makriyannis A 1996 I-123-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. European Journal of Pharmacology 307 331-338.
9. Hillard CJ, Farber NE, Hagen TC & Bloom AS 1984 The effects of delta-9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmacology, Biochemistry, and Behavior 20 547-550.
10. Klein TW 2005 Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews. Immunology 5 400-411.
11. Lomax P, Kokka N & George R 1970 Thyroid activity following intracerebral injection of morphine in rat. Neuroendocrinology 6 146-152.
12. Di Marzo V & Fontana A 1995 Anandamide, an endogenous cannabinomimetic eicosanoid: killing two birds with one stone. Prostaglandins, Leukotrienes, and Essential Fatty Acids 53 1-11.
13. Di Marzo V, Bifulco M & De Petrocellis L 2004 The endocannabinoid system and its therapeutic exploitation. Nature Reviews. Drug Discovery 3 771-784.
14. Matias I & Di Marzo V 2007 Endocannabinoids and the control of energy balance. Trends in Endocrinology and Metabolism 18 27-37.
15. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC & Bonner TI 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 561-564.
16. McLaughlin PJ, Winston KM, Limebeer CL, Parker LA, Makriyannis A & Salamone JD 2005 The cannabinoid CB1 antagonist AM251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology 180 286-293.
17. de Miguel R, Romero J, Munoz R, Garcia-Gil L, Gonzalez S, Villanua MA, Makriyannis A, Ramos JA & Fernandez-Ruiz JJ 1998 Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochemical Pharmacology 56 1331-1338.
18. Munro S, Thomas KL & Abushaar M 1993 Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 61-65.
19. Oliveira KJ, Paula GS, Costa-e-Sousa RH, Souza LL, Moraes DC, Curry FH & Pazos-Moura CC 2006 Peptide YY (PYY)3-36 modulates thyrotropin secretion in rats. Journal of Endocrinology 191 459-463.
20. Ortiga-Carvalho TM, Polak J, McCann S & Pazos-Moura CC 1996 Effect of thyroid hormones on pituitary neuromedin B and possible interaction between thyroid hormones and neuromedin B on thyrotropin secretion. Regulatory Peptides 67 47-53.
21. Ortiga-Carvalho TM, Oliveira KJ, Soares BA & Pazos-Moura CC 2002 The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies. Journal of Endocrinology 174 121-125.
22. Pagotto U, Marsicano G, Fezza F, Theodoropoulou M, Grubler Y, Stalla J, Arzberger T, Milone A, Losa M, Di Matzo V et al. 2001 Normal human pituitary gland and pituitary adenomas express cannabinoid recepror type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. Journal of Clinical Endocrinology and Metabolism 86 2687-2696.
23. Pazos-Moura CC, Moura EG, Rettori V, Polak J & McCann S 1996 Role of neuromedin B in the in vitro thyrotropin release in response to thyrotropin-releasing hormone (TRH) from anterior pituitaries of eu-, hypo- and hyperthyroid rats. Proceedings of the Society for Experimental Biology and Medicine 211 353-358.
24. Pertwee RG 2005 Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sciences 76 1307-1324.
25. Porcella A, Marchese G, Casu MA, Rocchitta A, Lai ML, Gessa GL & Pani L 2002 Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. European Journal of Endocrinology 147 255-261.
26. Rettori V, Milenkovic L, Fahim AM, Polak J, Bloom SR & McCann SM 1989 Role of neuromedin B in the control of the release of thyrotropin in the rat. PNAS 86 4789-4792.
27. Rettori V, Pazos-Moura CC, Moura EG, Polak J & McCann SM 1992 Physiological role of neuromedin B in control release of thyrotropin in hypothyroid and hyperthyroid rats. PNAS 89 3035-3039.
28. Scorticati C, Mohn C, De Laurentiis A, Vissio P, Solari JF, Sedicovich A, McCann SM & Rettori V 2003 The effect of anandamide on prolactin secretion is modulated by estrogen. PNAS 100 2134-2139.
29. Scorticati C, Fernandez-Solari J, De Laurentiis A, Mohn C, Prestifilippo JP, Lasaga M, Seilicovich A, Billi S, Franchi A, McCann SM et al. 2004 The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. PNAS 101 11891-11896.
30. Tsou K, Brown S, Sanudo-Pena MC, Mackie K & Walker JM 1998 Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 393-411.
31. Weidenfeld J, Feldman S & Mechoulam R 1994 Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-piturary-adrenal axis in the rat. Neuroendocrinology 59 110-112.
32. Weintraub BD, Kazlauskaite R, Grossmann M & Szkudlinski MW 2001 Thyroid-stimulating hormone and regulation of the thyroid axis. In Endocrinology, edn 4, pp 1345-1360. Eds L DeGroot & JL Jameson. Philadelphia: Saunders Company.
33. Wenger T, Toth BE & Martin BR 1995 Effects of anandamide (endogen cannabinoid) on anterior-pituitary hormone-secretion in adult ovariectomized rats. Life Sciences 56 2057-2063.
34. Wenger T, Jamali KA, Juanéda C, Léonardelli J & Tramu G 1997 Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. Biochemical and Biophysical Research Communications 237 724-728.
35. Wenger T, Fernandez-Ruiz JJ & Ramos JA 1999 Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. Journal of Neuroendocrinology 11 873-878.
36. Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X & Gardner EL 2006 Cannabinoid CB receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamateinthe nucleus accumbens. Journal of Neuroscience 26 8531-8536.
37. Zar J 1996 Data transformations. In Biostatistical Analysis, 3rd edn, pp 277-279. London: Prentice Hall International.